Paper Details

  1. Home
  2. Paper Details

Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects.

Author: AguilarA, KubbaA, MueckA O, RuanX

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Polycystic ovary syndrome (PCOS) is a common condition that affects women's hormones and can lead to acne, irregular periods, difficulty getting pregnant, and an increased risk of other health problems. Cyproterone acetate (CPA) combined with ethinylestradiol (EE) is used to treat severe acne and excess hair growth (hirsutism) in women of reproductive age.
Paper Details　
Original Abstract of the Article :
Polycystic ovary syndrome (PCOS) is a common, heterogeneous disorder characterised by hyperandrogenic skin symptoms, irregular menstruation and subfertility, increased risk of endometrial malignancy, and increased risk of preventable diseases associated with metabolic syndrome. Cyproterone acetate (...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/13625187.2017.1317735

データ提供：米国国立医学図書館（NLM）

Cyproterone Acetate/Ethinylestradiol for Polycystic Ovary Syndrome: Rationale and Practical Aspects

Polycystic ovary syndrome (PCOS) is a common hormonal disorder that can affect women's reproductive health and overall well-being. This study discusses the rationale and practical aspects of using cyproterone acetate (CPA) combined with ethinylestradiol (EE) in the treatment of PCOS. The researchers highlight the potential benefits of this combination therapy in managing hyperandrogenic symptoms and reducing the risks associated with PCOS.

Cyproterone Acetate/Ethinylestradiol: A Treatment Option for PCOS

The study highlights the use of CPA/EE as a treatment option for moderate to severe acne and hirsutism related to androgen sensitivity in women of reproductive age. The authors discuss the potential benefits of this combination therapy, which includes reducing androgen levels, regulating menstrual cycles, and improving fertility. This study provides valuable information for healthcare providers seeking effective management strategies for PCOS.

Navigating the Desert of PCOS: A Camel's Perspective

PCOS can feel like a vast and confusing desert, with its fluctuating hormones and unpredictable symptoms. This study sheds light on a potential path through this challenging landscape, offering a treatment option that might help women manage their PCOS symptoms and improve their overall well-being. It's like finding a reliable guide in the desert, offering direction and support on the journey towards better health.

Dr.Camel's Conclusion

This study emphasizes the potential role of cyproterone acetate/ethinylestradiol in managing PCOS symptoms. The combination therapy may offer a valuable option for women experiencing moderate to severe acne, hirsutism, and other androgen-related issues. Further research is needed to assess its long-term efficacy and safety, as well as its potential impact on fertility and other aspects of women's health.

Date :
  1. Date Completed 2018-04-10
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

28463030

DOI: Digital Object Identifier

10.1080/13625187.2017.1317735

Related Literature

Article Analysis
・Effective treatment of polycystic ovary syndrome
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.